Airway hyperresponsiveness to methacholine in 7-year-old children: sensitivity and specificity for pediatric

Chris Carlsten1, Helen Dimich-Ward, Alexander Ferguson

  • 1Department of Medicine, Chan-Yeung Centre for Occupational and Environmental Respiratory Disease, University of British Columbia, Vancouver, BC. chris.carlsten@vch.ca

Pediatric Pulmonology
|October 22, 2010
PubMed

Insights

The PC(20) methacholine challenge test for childhood asthma diagnosis shows a PC(20) 3 mg/ml cut-off offers the best balance of sensitivity and specificity. This finding aids in understanding airway hyperresponsiveness in pediatric asthma diagnosis.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology
  • Diagnostic Accuracy in Asthma

Background:

  • Understanding the operating characteristics of PC(20) cut-offs is crucial for diagnosing asthma in children.
  • Current cut-offs for airway hyperresponsiveness lack comprehensive evaluation in pediatric populations.
  • This study examines a unique birth cohort to address these knowledge gaps.

Purpose of the Study:

  • To determine the sensitivity and specificity of various PC(20) cut-off values for diagnosing asthma in children.
  • To evaluate incremental PC(20) thresholds for allergist-diagnosed asthma.
  • To inform optimal cut-off selection for methacholine challenge testing.

Main Methods:

  • A birth cohort of children at high risk for asthma underwent airway reactivity assessment at age 7.
  • Methacholine PC(20) values were determined using standard techniques with interpolation.
  • Asthma diagnosis was made by a pediatric allergist blinded to methacholine challenge results.
  • Sensitivity and specificity were calculated for PC(20) cut-offs ranging from 1.0 to 8.0 mg/ml, analyzed via ROC curves.

Main Results:

  • 20.1% of the 348 children were diagnosed with asthma.
  • For all children and females, the optimal PC(20) cut-off was 3 mg/ml (sensitivity 80.0%, specificity 49.1%), and the balanced cut-off was 2 mg/ml (sensitivity 63.1%, specificity 64.7%).
  • For males, both optimal and balanced PC(20) cut-offs were 2 mg/ml.

Conclusions:

  • A PC(20) cut-off of 3 mg/ml provided the maximal sum of sensitivity and specificity for this high-risk pediatric asthma cohort.
  • The choice of PC(20) cut-off should consider the desired balance between sensitivity and specificity for clinical application.
  • Findings suggest that PC(20) 3 mg/ml is a valuable threshold for methacholine challenge testing in 7-year-olds at high risk for asthma.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...